Skip to main content
. Author manuscript; available in PMC: 2020 Aug 2.
Published in final edited form as: Int J Gynecol Cancer. 2019 Jul 27;29(7):1156–1163. doi: 10.1136/ijgc-2019-000374

Table 3.

CA125 values during treatment

Time point ≤3 cycles post-operatively (n=41) >3 cycles post-operatively (n=59) P value

Prior to cycle 1 1085 (165.7–23 665.3) 1145.7 (13.1–26 000.0) 0.85
Following three neoadjuvant cycles 26.7 (2.8–102.0) 50.0 (6.1–3401.0) 0.27
After interval cytoreductive surgery 24.5 (7.0–316.0) 43.0 (6.0–1708.0) 0.18
Following three post-operative cycles 9.5 (1.5–36.0) 13.8 (3.0–34.0) 0.02
Following completion of all therapy 8.9 (1.5–36.0) 10.0 (3.0–29.0) 0.29
Cycle number after which CA125 normalized 3 (0–5) 4 (0–6) 0.03

All values shown as median (range).